NCT01853449View on ClinicalTrials.gov

Inhaled Fentanyl Citrate & Dyspnea

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions
Dyspnea
Interventions
DRUG

Fentanyl Citrate

OTHER

CWS

Chest wall strapping to reduce vital capacity by 20% of its baseline value

DRUG

Placebo

0.9% saline

Trial Locations (1)

H2X 2P4

Montreal Chest Institute; McGill University Health Center & McGill University, Montreal

All Listed Sponsors
lead

McGill University

OTHER

NCT01853449 - Inhaled Fentanyl Citrate & Dyspnea | Biotech Hunter | Biotech Hunter